Skip to main content
2025 IDWeek Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
Live Streamed
On Demand
On Demand
View Session Discussion + Q&A

Adult ID

Epi & Infection Control

Global ID

Investigative ID

HIV-STD-TB

Pediatric ID

Trainee

Transplant

COVID-19
Session Type: Named Lecture

107 - Maxwell Finland Lecture

Tuesday, October 21, 2025
9:15 AM - 10:00 AM US ET
Location: Ballroom (Hall B1)

Live Streamed On Demand
CME Credits: Maximum of .50 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of .50 hours of MOC Credit
CNE Credits: Maximum of .50 hours of ANCC Credit
ACPE Credits: ACPE .50 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

    Moderator(s)

  • Yohei Doi, MD, PHD (he/him/his)

    Professor of Medicine
    Division of Infectious Diseases
    University of Pittsburgh
    Toyoake, Aichi, Japan

    • Faculty(s)

  • Cesar Arias, MD/PhD

    Professor
    Division of Infectious Diseases, Department of Medicine.
    Houston Methodist and Weill Cornell Medical College
    Houston, TX, United States

Disclosure(s):
Yohei Doi, MD, PHD: GSK: Advisor/Consultant; Meiji Seika Pharma: Advisor/Consultant; Shionogi: Advisor/Consultant, Honoraria
Cesar A. Arias, MD/PhD: UptoDate: Royalties

Maxwell Finland, MD, DSci, served as the first president of IDSA. His prestigious medical career spanned more than 50 years at Harvard University and Boston City Hospital. He was internationally recognized for his study of the incidence and character of infectious diseases and their specific treatments. He is credited with influencing the pioneering of studies of antibiotic therapy and establishing early identification of new infectious hazards. The Maxwell Finland Lecture, which bears his name, was first given in 1972 by Theodore E. Woodward, MD.

Learning Objectives:

At the conclusion of this session, participants will be able to:
  • understand the complexities of antimicrobial resistance and how a translational approach can help individualized care at the bedside;
  • discuss a mechanistic-based approach for antibiotic selection against the most difficult to treat pathogens;
  • identify the complex interactions between antibiotics and infecting and colonizing multidrug-resistant organisms.

Presentations:

  • 9:15 AM - 9:35 AM US ET
    Awards Presentation
  • 9:35 AM - 10:00 AM US ET
    Antimicrobial Resistance at the Bedside: Translating Science into Patient Outcomes

    Speaker: Cesar A. Arias, MD/PhD – Houston Methodist and Weill Cornell Medical College